These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ras-family gene mutations in neoplasia of the ampulla of Vater. Scarpa A; Zamboni G; Achille A; Capelli P; Bogina G; Iacono C; Serio G; Accolla RS Int J Cancer; 1994 Oct; 59(1):39-42. PubMed ID: 7927901 [TBL] [Abstract][Full Text] [Related]
4. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Howe JR; Klimstra DS; Cordon-Cardo C; Paty PB; Park PY; Brennan MF Clin Cancer Res; 1997 Jan; 3(1):129-33. PubMed ID: 9815548 [TBL] [Abstract][Full Text] [Related]
5. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484 [TBL] [Abstract][Full Text] [Related]
6. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
7. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater. Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687 [TBL] [Abstract][Full Text] [Related]
8. Frequent somatic mutations of the APC and p53 genes in sporadic ampullary carcinomas. Imai Y; Oda H; Tsurutani N; Nakatsuru Y; Inoue T; Ishikawa T Jpn J Cancer Res; 1997 Sep; 88(9):846-54. PubMed ID: 9369932 [TBL] [Abstract][Full Text] [Related]
9. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases. McCarthy DM; Hruban RH; Argani P; Howe JR; Conlon KC; Brennan MF; Zahurak M; Wilentz RE; Cameron JL; Yeo CJ; Kern SE; Klimstra DS Mod Pathol; 2003 Mar; 16(3):272-8. PubMed ID: 12640108 [TBL] [Abstract][Full Text] [Related]
10. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992 [TBL] [Abstract][Full Text] [Related]
11. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
12. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644 [TBL] [Abstract][Full Text] [Related]
13. APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis. Achille A; Scupoli MT; Magalini AR; Zamboni G; Romanelli MG; Orlandini S; Biasi MO; Lemoine NR; Accolla RS; Scarpa A Int J Cancer; 1996 Nov; 68(3):305-12. PubMed ID: 8903471 [TBL] [Abstract][Full Text] [Related]
14. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131 [TBL] [Abstract][Full Text] [Related]
15. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. Sturm PD; Hruban RH; Ramsoekh TB; Noorduyn LA; Tytgat GN; Gouma DJ; Offerhaus GJ J Pathol; 1998 Nov; 186(3):247-53. PubMed ID: 10211112 [TBL] [Abstract][Full Text] [Related]
16. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617 [TBL] [Abstract][Full Text] [Related]
17. A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma. Ohnishi T; Tomita N; Monden T; Ohue M; Yana I; Takami K; Yamamoto H; Yagyu T; Kikkawa N; Shimano T; Monden M Br J Cancer; 1997; 75(3):341-7. PubMed ID: 9020477 [TBL] [Abstract][Full Text] [Related]
18. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene. Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045 [TBL] [Abstract][Full Text] [Related]
20. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater. Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]